Shares of HIMS experienced a dramatic decline today following the unexpected withdrawal of its deal with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending the company's stock price plummeting by over 20%. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that it cou